STAT3-Luc/EF1α-mCherry Reporter Cell Line - HepG2

The HepG2 cell line, derived from human hepatocellular carcinoma, is a well-established model in biomedical research due to its ability to retain many of the metabolic functions of primary hepatocytes. The STAT3-Luc/EF1α-mCherry Reporter Cell Line - HepG2 is a sophisticated modification of this parental line, engineered to provide a dual-modality readout of the Signal Transducer and Activator of Transcription 3 (STAT3) signaling pathway. This reporter system consists of a firefly luciferase gene driven by a STAT3-responsive element, paired with a constitutively expressed mCherry fluorescent protein under the control of the EF1α promoter. This setup allows for the sensitive and quantitative measurement of STAT3-mediated transcriptional activity through bioluminescence. Meanwhile, the mCherry reporter serves as a vital internal standard, allowing for normalization of cell numbers and assessment of cell health across different experimental conditions.

This engineered cell line serves as a powerful platform for the high-throughput screening of small molecule inhibitors or biologics targeting the JAK/STAT signaling pathway, which is often hyperactivated in various cancers and inflammatory disorders. It is particularly effective for characterizing the dynamics of cytokine-induced signaling, such as the liver’s response to Interleukin-6 (IL-6), a key activator of STAT3. The integration of both luciferase and mCherry enables high-precision data collection, where the fluorescent signal compensates for variations in cell density or potential cytotoxicity of tested compounds. Furthermore, the stable expression of mCherry makes these cells suitable for advanced applications, including live-cell imaging and the monitoring of tumor growth in xenograft models. By streamlining the quantification of signal transduction, the STAT3-Luc/EF1α-mCherry HepG2 cell line facilitates the rapid identification of novel therapeutic candidates and provides a reliable tool for investigating the complex molecular interactions governing liver pathophysiology and systemic inflammation.